Xinjing Wang MD, PhD, FACMG
Dr. Wang is board certified by the American Board of Medical Genetics and Genomics (ABMGG) in Clinical Molecular Genetics and Clinical Cytogenetics and previously served as the Associate Director of Genetics Laboratory, Department of Pediatrics at The University of Oklahoma Health Sciences Center. He earned his medical degree from Beijing University and earned his Ph.D. at The SUNY, Buffalo. Dr. Wang completed his Clinical Fellowships in Molecular Genetics and Clinical Cytogenetics at Johns Hopkins University, McKusick-Nathans Institute of Genetic Medicine. Prior to OUHSC genetics laboratory, Dr. Wang was the Director of the NEI DNA Diagnostics Laboratory in National Eye Institute/NIH in Bethesda, Maryland. He also served as the Medical Director of Molecular Diagnostics Laboratory, Department of Laboratory Medicine and Pathology at the University of Minnesota, Assistant Laboratory Director at Johns Hopkins University School of Medicine, McKusick-Nathans Institute of Genetic Medicine in Baltimore, Maryland. Dr. Wang is also the Director of Clinical Genomics at Health Network Laboratories, Allentown, Pennsylvania, the owner of CTGT.
Kerry Kocher Brown, PhD, FACMG
Associate Medical Director
Dr. Brown is board certified in clinical molecular genetics and clinical cytogenetics by the American Board of Medical Genetics. She earned her PhD in genetics from Harvard Medical School where she investigated genetic causes of hearing loss. She completed a fellowship in clinical laboratory genetics through the Harvard Medical School Genetics Training Program, which included molecular genetics training at the Partners Healthcare Laboratory for Molecular Medicine, cytogenetics training at the Brigham and Women’s Hospital Cytogenetics Laboratory, and research in the field of cardiovascular genetics. Dr. Brown is a fellow of the American College of Medical Genetics and Genomics (ACMG) and has served on the ACMG Laboratory Quality Assurance Committee, where she assisted in the development of guidelines for interpretation of copy number variation and for implementation of next-generation sequencing technologies in clinical laboratories. Dr. Brown is the Associate Medical Director at CTGT.